1 Min Read
July 6 (Reuters) - GlycoMimetics Inc
* GlycomiMetics Inc says to receive European patent for GMI-1271; will have claims directed at GMI-1271 extending at least until 2032 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.